Results
1 -
10 of
11The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission, Naunyn-Schmiedeberg's Archives of Pharmacology An In Vitro Methodology for Forecasting Luminal Concentrations and Precipitation of Highly Permeable Lipophilic Weak Bases in the Fasted Upper Small Intestine, Pharmaceutical Research Future drugs for migraine, Internal and Emergency Medicine Do TRPV1 antagonists increase the risk for skin tumourigenesis? A collaborative in vitro and in vivo assessment, Cell Biology and Toxicology Use of sensory methods for detecting target engagement in clinical trials of new analgesics, Neurotherapeutics New Therapies for Allergic Rhinitis, Current Allergy and Asthma Reports Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases, Archives of Pharmacal Research The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration, The AAPS Journal